B2B
Werewolf Therapeutics
Waltham, United Stateswerewolftx.com
Werewolf Therapeutics develops conditionally activated immunotherapies that selectively stimulate the immune system within the tumor microenvironment to treat cancer while minimizing off-target effect
aliveseries-b
series-b
Stage
3
Funding Rounds
About
Werewolf Therapeutics develops conditionally activated immunotherapies that selectively stimulate the immune system within the tumor microenvironment to treat cancer while minimizing off-target effects.
Explore Werewolf Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.